夏枯草口服液治疗甲状腺肿大/结节类甲状腺疾病临床应用专家共识  

Expert consensus statement on treatment of goiter/nodular thyroid disease with Xiakucao Oral Liquid in clinical practice

作　　者：无 魏军平 

机构地区：[1]夏枯草口服液临床应用共识专家组 [2]不详

出　　处：《中草药》2020年第8期2082-2087,共6页Chinese Traditional and Herbal Drugs

摘　　要：夏枯草口服液是《中国药典》2010年版和2015年版(一部)收录的常用中成药,是通过现代工艺提取浓缩制成的现代夏枯草制剂,具有清火、散结、消肿等功效。中华中医药学会外科学分会组织编写的《中成药临床应用指南·外科疾病分册》推荐夏枯草口服液用于治疗甲状腺疾病。国家中医药管理局2017年发布的《瘿痛(亚急性甲状腺炎)中医诊疗方案》(试行版)中推荐夏枯草口服液用于治疗瘿痛(亚急性甲状腺炎)。但夏枯草口服液在临床应用中仍存在许多问题。为规范夏枯草口服液治疗甲状腺疾病的临床用药,使更多的甲状腺疾病患者从中获益,依据现有临床研究结果,结合临床专家既往用药经验,特制订本专家共识(征求意见稿)。Xiakucao Oral Liquid is a commonly used proprietary Chinese medicine included in the 2010 and 2015 edition of Chinese Pharmacopoeia(part I). It is a preparation of Prunellae Spica made by extraction and concentration through modern technology, with the functions of clearing fire, dispersing nodules and swelling and so on. The Clinical Application Guide of Proprietary Chinese Medicine · Surgical Diseases Fascicule organized and compiled by the Surgery Branch of China Association of Chinese Medicine recommends Xiakucao Oral Liquid to treat thyroid diseases. Chinese Medicine Diagnosis and Treatment Scheme of Gall Pain(subacute thyroiditis) issued by the State Administration of Traditional Chinese Medicine in 2017(trial version) recommended Xiakucao Oral Liquid for the treatment of gall pain(subacute thyroiditis). However, there are still some problems in clinical application of Xiakucao Oral Liquid. In order to standardize the clinical use of Xiakucao Oral Liquid in the treatment of thyroid diseases and make more patients with thyroid diseases benefit from it, this expert consensus(exposure draft) is hereby formulated based on the existing clinical research results and combined with the previous experience of clinical experts in the treatment of thyroid diseases.

关 键 词：夏枯草口服液 甲状腺肿大 甲状腺结节 临床应用 专家共识 

分 类 号：R285.6[医药卫生—中药学]